SCHEMBL24326293

SCHEMBL24326293

Cc1cccc(C)c1-c1cc(O)nc(NSc2cccc(N3CCCN(C(=O)OC(C)(C)C)C[C@@H]3CC(C)(C)C)c2)n1

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMARCA2 P51531 2/20 0.33
SMARCA4 P51532 2/20 0.33
PBRM1 Q86U86 2/20 0.33
USP30 Q70CQ3 4/20 0.32
GPR119 Q8TDV5 1/20 0.32
TRPV3 Q8NET8 2/20 0.32
PARP1 P09874 1/20 0.32
ACKR3 P25106 1/20 0.32
IRAK1 P51617 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
MMP1 P03956 1/20 0.30
MMP9 P14780 1/20 0.30
MMP13 P45452 1/20 0.30
KAT7 O95251 1/20 0.30
KAT8 Q9H7Z6 1/20 0.30
PIM1 P11309 2/20 0.30
PIM2 Q9P1W9 2/20 0.30
TGM2 P21980 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24326280 0.88 NR1H2 (0.34) SMARCA2SMARCA4PBRM1USP30GPR119
SCHEMBL24325821 0.84 GPR119 (0.41) SMARCA2SMARCA4PBRM1GPR119MEN1
SCHEMBL24326273 0.76 GPR119 (0.37) GPR119
SCHEMBL24326160 0.75 NR1I2 (0.30) SMARCA2SMARCA4PBRM1
SCHEMBL24325770 0.75 TRPV3 (0.35) USP30TRPV3PARP1MMP1MMP9
SCHEMBL24325771 0.73 GPR119 (0.33) USP30GPR119TRPV3PARP1MEN1
SCHEMBL24326398 0.73 MEN1 (0.37) USP30TRPV3PARP1MEN1KMT2A
SCHEMBL24326719 0.73 GPR119 (0.34) USP30GPR119TRPV3PARP1
SCHEMBL27012855 0.73 MAP3K7 (0.31)
SCHEMBL27012691 0.72 GRIN2B (0.36) PARP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076625-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed